JP2018502101A5 - - Google Patents

Download PDF

Info

Publication number
JP2018502101A5
JP2018502101A5 JP2017534534A JP2017534534A JP2018502101A5 JP 2018502101 A5 JP2018502101 A5 JP 2018502101A5 JP 2017534534 A JP2017534534 A JP 2017534534A JP 2017534534 A JP2017534534 A JP 2017534534A JP 2018502101 A5 JP2018502101 A5 JP 2018502101A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
compound
heteroatom
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017534534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018502101A (ja
JP6772141B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2015/098367 external-priority patent/WO2016101885A1/en
Publication of JP2018502101A publication Critical patent/JP2018502101A/ja
Publication of JP2018502101A5 publication Critical patent/JP2018502101A5/ja
Application granted granted Critical
Publication of JP6772141B2 publication Critical patent/JP6772141B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017534534A 2014-12-24 2015-12-23 ネクローシス阻害薬 Active JP6772141B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2014/094735 2014-12-24
CNPCT/CN2014/094735 2014-12-24
PCT/CN2015/098367 WO2016101885A1 (en) 2014-12-24 2015-12-23 Necrosis inhibitors

Publications (3)

Publication Number Publication Date
JP2018502101A JP2018502101A (ja) 2018-01-25
JP2018502101A5 true JP2018502101A5 (https=) 2019-01-31
JP6772141B2 JP6772141B2 (ja) 2020-10-21

Family

ID=56149283

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017534534A Active JP6772141B2 (ja) 2014-12-24 2015-12-23 ネクローシス阻害薬

Country Status (8)

Country Link
US (2) US9974762B2 (https=)
EP (1) EP3224237B1 (https=)
JP (1) JP6772141B2 (https=)
KR (1) KR102606064B1 (https=)
CN (2) CN115197098B (https=)
AU (1) AU2015371822B2 (https=)
CA (1) CA2972366C (https=)
WO (1) WO2016101885A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3229807A4 (en) 2014-12-11 2018-10-17 President and Fellows of Harvard College Inhibitors of cellular necrosis and related methods
AU2015371822B2 (en) * 2014-12-24 2020-04-09 National Institute Of Biological Sciences, Beijing Necrosis inhibitors
MA44007A (fr) 2016-02-05 2018-12-19 Denali Therapeutics Inc Inhibiteurs du récepteur interagissant avec protéine kinase 1
HRP20220636T1 (hr) 2016-12-09 2022-07-22 Denali Therapeutics Inc. Spojevi korisni kao inhibitori ripk1
EP3672934A4 (en) * 2017-08-21 2021-05-05 Plex Pharmaceuticals, Inc. DOUBLE ACTING FKBP12 AND FKBP52 INHIBITORS
EP3883918B1 (en) * 2018-11-20 2023-07-19 Sironax Ltd Rip1 inhibitors
EP3811937A1 (en) * 2019-10-24 2021-04-28 Sorbonne Universite Compounds for use in the prevention and/or treatment of non-alcoholic fatty liver disease
WO2021138694A1 (en) * 2020-01-02 2021-07-08 Accro Bioscience Inc. Heteroaryl compounds as inhibitors of programmed necrosis pathway, composition and method using the same
CN115697991B (zh) 2020-05-20 2024-11-22 维泰瑞隆有限公司 哌嗪环状脲
EP4308555A4 (en) * 2021-03-18 2025-07-30 Sironax Ltd RECEPTOR-INTERACTING PROTEIN-1 INHIBITORS, PREPARATIONS AND USES THEREOF
CA3218159A1 (en) 2021-05-20 2022-11-24 Zhaolan ZHANG Rip1 modulators including azetidine cyclic ureas, preparations, and uses thereof
KR20240135076A (ko) 2021-08-10 2024-09-10 애브비 인코포레이티드 니코틴아미드 ripk1 억제제
US20240409501A1 (en) * 2021-10-22 2024-12-12 Sironax Ltd. Cyrstalline forms of rip1 inhibitor
JP2024540522A (ja) 2021-11-19 2024-10-31 ザ・ブロード・インスティテュート・インコーポレイテッド キナーゼを標的結合部分で標識するための二官能性キメラ分子及びその使用方法
IL314082A (en) 2022-01-12 2024-09-01 Denali Therapeutics Inc Crystal forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazapin-3-yl)- H4- 1,2,4-triazole-3-carboxamide

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3498792A (en) * 1965-08-07 1970-03-03 Fuji Photo Film Co Ltd Silver halide photographic compositions containing a sulfinamide as a fog inhibitor
US4405357A (en) * 1980-06-02 1983-09-20 Fmc Corporation Herbicidal 3-isoxazolidinones and hydroxamic acids
US4337332A (en) * 1981-04-09 1982-06-29 Minnesota Mining And Manufacturing Company Latently curable organosilicone compositions
GB8531839D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
US4957533A (en) * 1987-10-26 1990-09-18 Eli Lilly And Company N-phenylalkylbenzamide fungicides
US5189180A (en) * 1989-09-28 1993-02-23 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
US6756394B1 (en) 1999-10-15 2004-06-29 President And Fellow Of Harvard College Small molecule inhibitors of necrosis
US6706766B2 (en) 1999-12-13 2004-03-16 President And Fellows Of Harvard College Small molecules used to increase cell death
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
SI2384753T1 (sl) 2003-08-29 2016-06-30 The Brigham And Women's Hospital, Inc. Hidantoinski derivati kot inhibitorji celične nekroze
CN100584842C (zh) * 2004-03-05 2010-01-27 大正制药株式会社 噻唑衍生物
NZ549003A (en) * 2004-03-05 2009-07-31 Taisho Pharmaceutical Co Ltd Thiazole derivative as an ALK5 inhibitor
TWI407960B (zh) * 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
US20090099242A1 (en) 2007-08-15 2009-04-16 Cuny Gregory D Heterocyclic inhibitors of necroptosis
WO2010075290A1 (en) 2008-12-22 2010-07-01 President And Fellows Of Harvard College Unsaturated heterocyclic inhibitors of necroptosis
CA2772760A1 (en) * 2008-12-23 2010-07-01 President And Fellows Of Harvard College Small molecule inhibitors of necroptosis
PE20130010A1 (es) * 2010-02-26 2013-02-05 Japan Tobacco Inc Derivado de 1,3,4,8-tetrahidro-2h-pirido[1,2-a]pirazina como inhibidor de la integrasa del vih
AR084174A1 (es) * 2010-12-21 2013-04-24 Lilly Co Eli Compuestos de imidazol-2-benzamida utiles para el tratamiento de osteoartritis y una composicion farmaceutica
WO2012125544A2 (en) * 2011-03-11 2012-09-20 President And Fellows Of Harvard College Necroptosis inhibitors and methods of use therefor
CN102503860A (zh) * 2011-11-14 2012-06-20 武汉大学 一种1,3-二取代脲和氨基甲酸酯的合成方法
CN102617259B (zh) * 2012-03-09 2014-12-24 温州大学 一种醇与胺脱水合成胺类化合物的方法
JP6410790B2 (ja) * 2013-03-14 2018-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ミトコンドリアアルデヒドデヒドロゲナーゼ−2調節因子およびその使用方法
US9725452B2 (en) * 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
TWI651310B (zh) * 2014-02-20 2019-02-21 日商日本煙草產業股份有限公司 三化合物及其醫藥用途
AU2015371822B2 (en) * 2014-12-24 2020-04-09 National Institute Of Biological Sciences, Beijing Necrosis inhibitors

Similar Documents

Publication Publication Date Title
JP2018502101A5 (https=)
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
JP2009504763A5 (https=)
RU2013155586A (ru) [1,3]оксазины
JP2019521988A5 (https=)
JP2013512903A5 (https=)
RU2014141579A (ru) Гетероциклические соединения в качестве ингибиторов бета-лактамаз
RU2014131014A (ru) Димерные соединения-агонисты рецептора fgf (fgfr), способ их получения и их терапевтическое применение
JP2014037426A5 (https=)
JP2018524390A5 (https=)
JP2015537020A5 (https=)
JP2010524932A5 (https=)
JP2006524222A5 (https=)
RU2013137452A (ru) Композиции, содержащие расщепляемое ферментами пролекарство оксикодона
JP2009507896A5 (https=)
RU2019141734A (ru) Терапевтические соединения и композиции и способы их применения
RU2015121037A (ru) Производные фенилэтилпиридина в качестве ингибиторов pde-4
RU2017145930A (ru) МОДУЛЯТОРЫ ROR ГАММА (RORγ)
RU2015117647A (ru) Новые производные пиразола
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
RU2008136762A (ru) Циклические сульфоны как ингибиторы васе
JP2013537240A5 (https=)
RU2012146874A (ru) Производные пиразолопиридина
JP2016523830A5 (https=)
RU2014134845A (ru) Терапевтическое средство против диабета